Global Head of Mergers
Flavia writes about merger control, antitrust enforcement and litigation in the U.S. and Brazil. Before joining MLex, Flavia worked as an Antitrust Consultant in the Federal Trade Commission's Office of International Affairs and as a Research Fellow for the American Antitrust Institute. She has written on the intersection of antitrust law and intellectual property law in technology-driven and innovative markets.
Flavia holds a LL.M. in intellectual property from the George Washington University Law School and a Bachelor of Laws from the Universidade Federal de Minas Gerais in Brazil. She is admitted to the bar in New York and Brazil.
Selected Insights by Flavia
US antitrust policy has remained largely consistent across administrations, but uncertainty looms with electionUS antitrust policy hasn’t seen major shifts in enforcement between presidential administrations in decades.
The federal judge who approved T-Mobile's plan to buy Sprint said the usual presumptions in antitrust law don't work in this case because of the specifics of the dynamic, rapidly changing mobile wireless industry.
Abbvie has withdrawn the antitrust paperwork for its $63 billion purchase of Allergan with the US Federal Trade Commission, MLex has learned.
Since a recent change in policy by the US Department of Justice to streamline merger reviews, all new investigations are on track for closing within six months, a senior DOJ official said.